https://scholars.lib.ntu.edu.tw/handle/123456789/537374
標題: | Hepatitis B reactivation during treatment of tyrosine kinase inhibitors—Experience in 142 adult patients with chronic myeloid leukemia | 作者: | Wang Y.-H. JA-DER LIANG WANG-HUEI SHENG FENG-MING TIEN Chen, Chien-Yuan HWEI-FANG TIEN |
公開日期: | 2019 | 出版社: | Elsevier Ltd | 卷: | 81 | 起(迄)頁: | 95-97 | 來源出版物: | Leukemia Research | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065013832&doi=10.1016%2fj.leukres.2019.05.001&partnerID=40&md5=42822f64f3fee2a6ea1f1519c7b0e1c7 https://scholars.lib.ntu.edu.tw/handle/123456789/537374 |
ISSN: | 0145-2126 | DOI: | 10.1016/j.leukres.2019.05.001 | SDG/關鍵字: | dasatinib; entecavir; hepatitis B antibody; hepatitis B core antibody; hepatitis B surface antigen; hepatitis B(e) antigen; imatinib; nilotinib; ponatinib; protein tyrosine kinase inhibitor; virus DNA; protein kinase inhibitor; adult; aged; antiviral therapy; chronic myeloid leukemia; cohort analysis; female; follow up; hepatitis B; Hepatitis B virus; human; incidence; Letter; major clinical study; male; middle aged; priority journal; retrospective study; serology; treatment outcome; virus carrier; virus reactivation; young adult; adolescent; chronic myeloid leukemia; drug effect; hepatitis B; pathology; prognosis; Taiwan; very elderly; virology; virus activation; Adolescent; Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors; Retrospective Studies; Taiwan; Virus Activation; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。